Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Non-alcoholic Steatohepatitis (NASH) Cirrhosis: Twenty-Two Years Data from the Scientific Registry of Transplant Recipients (SRTR)

被引:0
|
作者
Younossi, Zobair M. [1 ,4 ]
Stepanova, Maria [2 ]
Locklear, Cameron T. [1 ]
Jacobson, Ira [3 ]
Mishra, Alita [1 ]
Trimble, Gregory [1 ]
Erario, Madeline [1 ]
Venkatesan, Chapy [1 ]
Younossi, Issah [2 ]
Arsalla, Aimal [4 ]
Keo, Wisna'odom [4 ]
Goodman, Zachary D. [1 ]
机构
[1] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[2] Ctr Outcomes Res Liver Dis, Washington Dc, DC USA
[3] Med Mt Sinai Beth Israel, New York, NY USA
[4] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1682
引用
收藏
页码:899A / 900A
页数:2
相关论文
共 31 条
  • [1] Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
    Golabi, Pegah
    Bush, Haley
    Stepanova, Maria
    Locklear, Cameron T.
    Jacobson, Ira M.
    Mishra, Alita
    Trimble, Gregory
    Erario, Madeline
    Venkatesan, Chapy
    Younossi, Issah
    Goodman, Zachary
    Younossi, Zobair M.
    MEDICINE, 2018, 97 (31)
  • [2] NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST COMMON INDICATION FOR LIVER TRANSPLANTATION (LT) AMONG THE ELDERLY: DATA FROM THE UNITED STATES SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR)
    Stepanova, Maria
    Kabbara, Khaled W.
    Mohess, Denise
    Roche-Green, Alva
    Verma, Manisha
    Younossi, Zobair M.
    HEPATOLOGY, 2021, 74 : 859A - 860A
  • [3] NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST RAPIDLY GROWING CAUSE OF LISTING FOR LIVER TRANSPLANTATION: THE SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR) DATA FROM 1994 TO 2018
    Younossi, Zobair M.
    Stepanova, Maria
    Ong, Janus
    Trimble, Gregory
    Ahmed, Aijaz
    Alqahtani, Saleh
    Younossi, Issah
    Racila, Andrei
    HEPATOLOGY, 2019, 70 : 697A - 698A
  • [4] Non-alcoholic fatty liver disease (NAFLD) after orthotopic liver transplantation (OLT) in patients with cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)
    Amaro, R
    Montalbano, M
    Acosta, RC
    Concha, R
    Weppler, D
    Neff, GW
    O'Brien, CB
    Molina, EG
    Schiff, ER
    Tzakis, AG
    GASTROENTEROLOGY, 2001, 120 (05) : A118 - A118
  • [5] Recurrence of Non-Alcoholic Steato-Hepatitis (NASH) and Cryptogenic Cirrhosis (CC) Following Liver Transplantation (LT) in the Context of Metabolic Syndrome
    Abouljoud, Marwan S.
    Elatrache, Mazen M.
    Yoshida, Atsushi
    Kim, Dean Y.
    Hundley, Jonathan C.
    Kazimi, Marwan M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 67 - 67
  • [6] Recurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Following Liver Transplantation for NASH Cirrhosis
    Matsuoka, Lea
    Slaughter, James
    Campbell, Kathyrn
    Kerr, Ashlie
    Hamel, Stephanie
    Garza, Carissa
    Chotai, Pranit
    Alexopoulos, Sophoclis
    Scanga, Andrew
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 15 - 15
  • [7] Recurrent steatosis following liver transplant for non-alcoholic steatohepatitis (NASH) or cryptogenic cirrhosis (CC); Histomorphologic and clinical follow-up in 231 patients
    Punia, J. N.
    Shah, V. V.
    Sherbondy, M. A.
    MODERN PATHOLOGY, 2007, 20 : 290A - 290A
  • [8] Recurrent steatosis following liver transplant for non-alcoholic steatohepatitis (NASH) or cryptogenic cirrhosis (CC); Histomorphologic and clinical follow-up in 231 patients
    Punia, J. N.
    Shah, V. V.
    Sherbondy, M. A.
    LABORATORY INVESTIGATION, 2007, 87 : 290A - 290A
  • [9] Systematic review: Does the evidence support an association between cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)?
    Angtuaco, TL
    Raj, V
    Oprescu, FG
    Beisel, JC
    Moore, JD
    Russell, BD
    Co, JM
    Howden, CW
    GASTROENTEROLOGY, 2003, 124 (04) : A383 - A384
  • [10] Predicting the outcome of liver transplantation in patients with non-alcoholic steatohepatitis cirrhosis: The NASH LT risk-benefit calculator
    Karnam, Ravikiran S. S.
    Punchhi, Gopika
    Mitsakakis, Nicholas
    Chen, Shiyi
    Saracino, Giovanna
    Lilly, Leslie
    Asrani, Sumeet K. K.
    Bhat, Mamatha
    CLINICAL TRANSPLANTATION, 2023, 37 (04)